The DiaCoVAb study in South Italy: immune response to Sars-CoV-2 vaccination in dialysis patients

Conclusion. These results prompt to suggest an additional vaccine dose in DP, reducing the interval of time from the second dose. Since few data are available on immune response in DP overtime after three vaccine doses currently, our study is among the first reports demonstrating the improved seropositivity and IgG levels in DP after booster vaccine dose.
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research